A SECRET WEAPON FOR MBL77

Not all people with CLL call for therapy. Despite all recent innovations, the iwCLL still endorses watchful observation for sufferers with asymptomatic disorder.86 This suggestion is based on at the very least two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 Bo